Pelican BioThermal, provider of temperature-controlled packaging, is celebrating the five-year anniversary of Credo on Reserve, its long-term rental program for the cold chain pharmaceutical distribution industry.
Credo on Reserve, which uses passive Credo Cube shippers, is geared toward pharmaceutical manufacturers with long-term and more predictable usage needs. Unlike the company’s Credo on Demand rental service, which offers daily and monthly rental rates, Credo on Reserve offers Pelican BioThermal customers dedicated inventory for longer rental periods.
“We’re extremely proud of the five years we’ve offered Credo Cube shippers to meet global customer needs through Credo on Reserve,” said Kevin Lawler, vice president of worldwide sales at Pelican BioThermal. “No other provider of temperature-controlled packaging offers a similar program that has the fleet of dedicated inventory, years of experience and worldwide infrastructure that Pelican BioThermal provides and has provided for five years.”
Credo on Reserve customers pay for a minimum number of trips during that period and a fixed rate on any trips beyond the minimum. This flexibility gives end users the always-available benefit of dedicated passive temperature-controlled shippers, combined with the benefit of replacing large capital costs with more manageable monthly operating costs.
“Medical device manufacturers prefer to focus on their core competencies of maximizing patient health, rather than building complex logistics and distribution systems,” said Lawler. “Our Credo on Reserve program is designed to give manufacturers maximum flexibility without the headache of managing reverse logistics, refurbishment, conditioning and the upfront investment in temperature-controlled shippers.”
The Credo on Reserve program includes Credo ProEnvision, a robust web-based asset management and optimization tool that provides real-time tracking and tracing of individual Credo temperature-controlled shippers throughout the entire distribution cycle.
Pelican BioThermal is a division of Pelican Products Inc, which is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.
For more information, visit www.pelicanbiothermal.com.